ITM to Share COMPETE Dosimetry Results and Organize Satellite Symposium at EANM 2025
Garching / Munich, Germany, September 16, 2025 – ITM, a prominent radiopharmaceutical biotech firm, confirmed today its plans to present dosimetry findings from its recently completed Phase 3 COMPETE trial. This presentation will occur during an oral session at the European
More